Targeting genotoxic and proteotoxic stress‐response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram
Majera, Dusana, Skrott, Zdenek, Bouchal, Jan, Bartkova, Jirina, Simkova, Dana, Gachechiladze, Mariam, Steigerova, Jana, Kurfurstova, Daniela, Gursky, Jan, Korinkova, Gabriela, Cwiertka, Karel, Hodny, Zdenek, Mistrik, Martin, Bartek, Jiri
Published in The Prostate (01.03.2019)
Published in The Prostate (01.03.2019)
Get full text
Journal Article